Daniel has over two years of experience advising on transactional matters relating to a broad range of contentious and non-contentious corporate and commercial matters in the corporate M&A, private equity and venture capital practice areas.

Daniel specialises in both company and investor side transactional matters with particular emphasis on the emerging company investment space. Daniel has advised on matters across multiple industries, ranging from early seed and angel based investments through private acquisition and public offering exits. He is a member of the Venture Capital team in the Corporate Commercial sector group.

Read More

Recent Experience

  • Lakestar Venture Capital, a leading European venture capital firm, on investments into a range of UK-based emerging companies with an aggregate value of over $60m.
  • Sandbox Industries, a US-based venture capital firm, on the $36m financing round into the medical software company Perspectum Limited.
  • Webster Equity Partners, a US-based private equity firm on its acquisition of a well-known brand management and creation company for a consideration price of over £50m.
  • G Square Healthcare Private Equity LLP, a UK-based healthcare private equity specialist, in the acquisition of a dental care platform via institutional buyout for an aggregate consideration price of £80m.
  • Various UK-based emerging companies including Notpla Limited, FlowerBx Limited, Cleo AI Limited, Northflank Limited and more in respect of investment funding rounds from international institutional investors.


  • English
  • French


2016 – Bachelors of Law, University of Edinburgh

2013 – Bachelors of Arts (Economics and Political Science), McGill University


2020 – England & Wales, Solicitor